@IT_HealthPlus@mccarthymt7 Perhaps someone at @roinnslainte or @HSELive can explain how they plan to have hospitals expand from a routine 5 day week to a routine 6 and 7 day week without hiring people to do that work.
It is a step in the right direction to publish this data.
The dashboard is here: https://t.co/4Axtbz0b0s
I presume the dataset is complete and accurate.
For some context, 15 years ago, in a public hospital clinic, for example, a consultant and 3 NCHDs would have an OPD of 60-80 people to see “scheduled” for a 3-4 hour clinic, that would routinely run for 6 hours. The consultant gave an opinion, and dictated a letter.
Today, many new consultants are in the clinic alone. They see all the patients, type their own letters, book the scans, request the molecular tests, arrange the follow up visits, and organise the interventions (e.g. chemotherapy appointments) by themselves.
Being a consultant has become a different job.
Fantastic academic opportunity to lead a robust and growing cancer clinical trials unit in Cork - great role to consider for established and emerging leaders in cancer care!
Congratulations to Maimoona Khalid awardee of the Dr Sheila Boland Scholarship in Public Health. This Scholarship will give Maimoona the opportunity to undertake her 8-week practicum at the University of Arizona.
@publichealthul@MedicineAtUL@ProfColumDunne@CumminsNM@ulglobal
Last night, celebrating Prof Ray McDermott was made truly special by having Ray’s family in the room, alongside friends, colleagues, doctors, funders, pharma reps, fundraisers & patients.
Esteemed international colleagues also joined us via video. Thank you to everyone who came together to say 'thank you' to Ray. 💙
@mccarthymt7@roinnslainte@ForvisMazars_ie Is the drug reimbursement process for public patients quicker by switching social media accounts from X to LinkedIn....then its a welcome move 😉
The Irish Medical Council (GMC equivalent in Ireland) are taking a stand!
They state:
“As the independent body which regulates doctors in Ireland, they are NOT the appropriate regulator for physician associates”
The 4 reasons they give below:
🧵
#FreshOffThePress
Our review article on late side effects in Testicular Cancer Survivors
Thanks to the co-authors and @TUHCancerTrials for their support
https://t.co/0DBxPZDYo6
Join our Mid-Western Cancer Centre as Consultant Medical Oncologist (L) - closing 28/11/24. Description in link below👇 @HSEMidWest
https://t.co/0lgTrWAJUH
Sustainability Tool Kit for Medical Oncologists 👇
Translated 🇪🇸🇮🇹🇸🇪🇩🇪🇵🇹🇫🇷🇳🇱 versions in suppl.
✍️led by Dr Emer Lynch @PhilipBredin
Why We Should, and How We Can, Reduce the Climate Toxicity of Cancer Care https://t.co/JZh6PAXuyC
Adjuvant mFOLFIRINOX for Resected Pancreatic Adenocarcinoma (PDAC): Clinical Insights and Genomic Features from a Large Contemporary Cohort https://t.co/r6a7eglKZM Congrats to @ferguskeane2@CatherineaOC@FiyinfoluB@DrewMoss for very thoughtful compilation synthesis of data!
At #UromigosLive24 we discussed the role of IO after IO with @brian_rini, @DrChoueiri, @TiansterZhang and David McDermott. Two randomized phase 3 trials have not shown any benefit to sequential PD-1/PDL-1-based therapy in RCC.